市场调查报告书
商品编码
1429022
全球眼科超音波检测市场评估:依产品、模式、最终用户、地区、机会、预测(2017-2031)Ophthalmic Ultrasound Market Assessment, By Product, By Modality, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球眼科超音波市场规模将从2023年的6.278亿美元增至2031年的11.5858亿美元,预计2024-2031年的复合年增长率为7.96%。 由于视力障碍盛行率不断上升以及对早期准确诊断的需求,全球眼科超音波市场正在迅速扩大。 老化是视力障碍的主要原因。 早期诊断对于管理随着老化而来的各种视力问题(例如黄斑部病变和老花眼)至关重要。 眼科超音波具有评估眼外伤、评估眼内肿瘤(包括尚未引起视力障碍的小肿瘤)的存在和位置、评估视网膜剥离和评估血管疾病的潜力。
眼科超音波检查的好处已广为患者所知,越来越多的人接受这种诊断影像设备。 技术进步、市场进入者推出的产品、医疗保健支出的增加以及可支配收入的增加在眼科超音波检测市场的成长中发挥着重要作用。 此外,改善获得眼部保健服务的机会,包括公私伙伴关係和合资企业投资于诊断设备的研发以及为社会经济地位较低的人提供更有效率和有效的诊断方法。政府的支持和举措正在进一步推动市场增长。
视力障碍盛行率不断增加
由于世界各地视力障碍人数不断增加,对眼科超音波检查的需求正在迅速增加。 眼科超音波是非侵入性的,能够提供眼部结构的详细影像,可用于诊断各种眼部疾病,如白内障、近视、远视、糖尿病视网膜病变、青光眼、老年黄斑部病变、老花眼等。管理中发挥重要作用。 据世界卫生组织称,全球有 22 亿人患有近距离视力或远端视力丧失。 据估计,全球每年与视力丧失相关的生产力成本高达 4,110 亿美元,给全球卫生系统带来了沉重的经济负担。 低收入和中等收入国家的视力障碍盛行率最高。 透过改善眼镜的使用以及使用眼科超音波进行准确诊断来进行早期发现和介入是控制视力障碍的关键。
眼科超音波技术的进展
超音波技术的技术创新实现了更高的成像能力,为临床医生提供了更高的眼部结构可视化精度和细节。 人工智慧与机器学习的融合,进一步提高了诊断准确性,快速且准确地检测眼部疾病。 超音波诊断设备的小型化提高了便携性并实现了即时诊断。 2023年6月,AI驱动的眼科超音波和AI疗效预测生物标记领域的全球领导者Eyenuk将使用拓普康的视网膜相机NW400,利用AI自动检测糖尿病视网膜病变,获得美国FDA批准。 如果及早发现,这种创新产品可以帮助糖尿病患者保留视力。
政府措施
认识到眼病负担日益加重以及对先进诊断设备的需求,许多政府正在製定支持采用眼科诊断设备的卫生政策和举措。 资助、研究资助和开发这些诊断设备的补助等计划鼓励医疗机构和从业人员将这些设备纳入他们的实践中。 2023 年 5 月,英国国家医疗服务体系 (NHS) 宣布实施新的临床指南,可以减少英格兰患者等待眼科护理服务的时间。 该倡议还旨在藉助眼科超音波设备等现代数位诊断设备来改善眼科护理的诊断和治疗。 这提高了患者眼部护理的速度和品质。
携带式眼科超音波检查的发展
在产品领域中,便携式眼科超音波检查预计在预测期内将快速成长。 该领域的技术进步促进了先进设备的发展,例如轻型便携式设备,可以为卧床患者和紧急情况提供定点护理服务。 许多主要市场参与者已经认识到该领域不断增长的需求,并正在推出新的高精度设备。 2023年8月,Alpinion医疗系统有限公司发布了便携式超音波诊断设备 "X-Cube i9" 。 配备双电池和探头连接器。 X-Cube i9 重量轻,高度便携,只需 1 分钟即可完成设置,待机模式下运行长达 100 小时,扫描模式下运行超过 1 小时。 该设备提供眼部筛检、帮助早期检测和快速分析,并提供床边护理。
本报告研究和分析了全球眼科超音波检查市场,提供市场规模和预测、市场动态、主要公司趋势和前景等。
Global ophthalmic ultrasound market is projected to witness a CAGR of 7.96% during the forecast period 2024-2031, growing from USD 627.8 million in 2023 to USD 1158.58 million in 2031. Due to the rising incidence of vision impairment and the resulting need for early and accurate diagnosis, the global ophthalmic ultrasound market is expanding rapidly. The growing geriatric population is the primary cause of vision impairment. Early diagnosis is crucial for managing various vision problems that arise with age, including macular degeneration and presbyopia. Ophthalmic ultrasound has the potential to provide evaluation of traumatic eye injuries, assessing presence and location of intraocular tumors, including small tumors that have not yet caused visual distortion, evaluation of retinal detachment and evaluation of vascular disease.
The benefits of ophthalmic ultrasounds are becoming more widely known to patients, which has increased acceptance of these diagnostic imaging devices. Technological advancements, product launches by the market players, increased healthcare expenditure, and increasing disposable incomes are playing a major role in the growth of the ophthalmic ultrasound market. Moreover, governmental support and initiatives to improve access to eye care services, such as diagnostic appliances for low socio-economic people and public and private firm's collaborations and joint ventures to invest in research and development of the more efficient and effective diagnostic approaches, further facilitate growth in the global ophthalmic ultrasound market.
Increasing Prevalence of Vision Impairments
There has been a surge in demand for ophthalmic ultrasound due to the rising number of vision impairments worldwide. Ophthalmic ultrasound, with its non-invasive nature and ability to provide detailed images of ocular structures, plays an important role in diagnosing and managing various eye conditions such as cataracts, myopia, hyperopia, diabetic retinopathy, glaucoma, age-related macular degeneration, and presbyopia. According to WHO, 2.2 billion people are suffering from near or distance vision impairment, globally. The annual global cost of productivity associated with vision impairment is estimated to be USD 411 billion, posing a massive financial burden on global healthcare systems. The prevalence of vision impairment is most common in low-and-middle-income-countries. Early detection and early intervention by improving access to eye wear and using ophthalmic ultrasounds for accurate diagnosis are crucial in managing vision impairment.
Technological Advancements in Ophthalmic Ultrasound
Technological innovations in ultrasound technology have enabled high imaging capabilities, providing clinicians with increased accuracy and details in visualizing ocular structures. The integration of artificial intelligence (AI) and machine learning has further facilitated diagnostic accuracy for faster and accurate detection of eye conditions. The miniaturization of ultrasound devices has led to portability, allowing point-of-care diagnostics. In June 2023, Eyenuk, a global leader in AI-based ophthalmic ultrasound and AI Predictive Biomarkers, received U.S. FDA clearance to use the Topcon NW400 retinal camera to automatically detect diabetic retinopathy with the use of AI. This innovative product would help the diabetic patients to save their vision by early detection.
Government Initiatives
Recognizing the growing burden of eye diseases and the need for advanced diagnostic devices, many governments have formulated healthcare policies and initiatives to support the adoption of ophthalmic diagnostic devices. Programs for funding, grants for research, and subsidies for the development of these diagnostic devices have encouraged medical facilities and practitioners to incorporate these devices into their practices. In May 2023, National Health Service (NHS) England announced the implementation of a new clinical guidance, which could reduce waiting times for eye care services for patients in England. The initiative also aims to provide improved eye care diagnosis and treatment with the help of latest digital diagnostic appliances such as ophthalmic ultrasound devices. This will improve the speed and quality of eye care treatment for patients.
Growth in Portable Ophthalmic Ultrasound
Among the product segment, portable ophthalmic ultrasound is expected to grow faster in the forecasted period. Technological advancements in this segment have led to the development of advanced devices, such as light-weight portable devices, that can provide point of care services to the bedridden patients and during emergency locations. Many key market players understand the growing demand of this segment and are launching modern devices with high accuracy and precision. In August 2023, Alpinion Medical Systems Co. Ltd. launched their portable ultrasound device "X-Cube i9". It is equipped with dual batteries and probe connectors. X-Cube i9 is lightweight, has extended portability and sets up in just one minute, providing up to 100 hours of standby mode and more than one hour of scan mode operation. This device will provide ophthalmic screening, be beneficial in early detection and quick analysis, and provide care at the bedside.
North America Holds Largest Share in Ophthalmic Ultrasound Market
North America accounts for a significant share in the global ophthalmic ultrasound market. Robust healthcare infrastructure and advanced healthcare facilities are some of the factors which make North America a global leader in the global healthcare market. Growing awareness of the importance and benefits of screening and early diagnosis in preventing eye diseases drives the global demand for ophthalmic ultrasound. High number of eye surgeries in the region, and availability of many surgeons further leads to increased application of ophthalmic ultrasounds for constant evaluation and screening of eye diseases. There are around 20 million cataract surgeries performed each year, and the United States accounts for 3.7 million surgeries performed each year. In 2020, ophthalmologists performed 800,000 laser refractive procedures and 47,000 corneal transplants in the United States. These surgeries consistently require screening and evaluation, which drives demand in demand in this region. Moreover, key market players like DGH Technology, Inc. and Escalon Medical Corp. play a pivotal role in the availability of advanced medical devices for ophthalmology.
Future Market Scenario
The global ophthalmic ultrasound market is expected to grow in the coming years due to several factors. The global prevalence of vision impairment will increase as the population grows old. This will increase the demand for ophthalmic ultrasound due to its ability to diagnose eye-related disorders with accuracy and precision. Ophthalmic ultrasounds are cost-effective and play a crucial role in providing early intervention. The public increasingly recognizes the importance of early diagnosis and disease prevention for disorders related to the eyes. Technological advancements, government programs, increasing healthcare budgets, and collaborative partnerships between medical device companies, research institutions, and other healthcare providers are some of the factors responsible for driving the market's growth over the forecast period.
Key Players Landscape and Outlook
In the ophthalmic ultrasound market, mergers and acquisitions, partnerships, and distribution agreements are pivotal in driving the global ophthalmic ultrasound market. These alliances empower firms to adapt to each other's strengths, gain access to new markets and technologies, and pool resources for research and development. Distribution agreements enable companies to expand their market presence. These collaborative initiatives promote innovation, expedite product development, and contribute to the growth of the ophthalmic ultrasound market. In October 2022, Halma Plc. announced the acquisition of IZI Medical Products, a leading designer, manufacturer and distributor of diagnostic devices. Through this acquisition the company aims to improve the quality of its diagnostic medical devices, such as ophthalmic ultrasound devices, and enhance its market on a global level.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work